Found: 76
Select item for more details and to access through your institution.
Safety and effectiveness of apremilast in Japanese patients with psoriatic disease: Results of a post‐marketing surveillance study.
- Published in:
- Journal of Dermatology, 2024, v. 51, n. 7, p. 950, doi. 10.1111/1346-8138.17270
- By:
- Publication type:
- Article
Consistent Efficacy of Apremilast in Patients with Psoriasis Regardless of Baseline Disease Severity or Special Area Involvement: Subgroup Analysis from PROMINENT.
- Published in:
- Dermatology & Therapy, 2024, v. 14, n. 6, p. 1587, doi. 10.1007/s13555-024-01179-z
- By:
- Publication type:
- Article
Bimekizumab safety in patients with moderate-to-severe plaque psoriasis: pooled data from up to 3 years of treatment in randomized phase III trials.
- Published in:
- British Journal of Dermatology, 2024, v. 190, n. 4, p. 477, doi. 10.1093/bjd/ljad429
- By:
- Publication type:
- Article
Deucravacitinib, an oral, selective, allosteric tyrosine kinase 2 inhibitor, in Japanese patients with moderate to severe plaque, erythrodermic, or generalized pustular psoriasis: Efficacy and safety results from an open‐label, phase 3 trial.
- Published in:
- Journal of Dermatology, 2024, v. 51, n. 3, p. 365, doi. 10.1111/1346-8138.17074
- By:
- Publication type:
- Article
MACULOPAPULAR CUTANEOUS MASTOCYTOSIS HARBORING A KIT MUTATION (ASP419DEL): A CASE REPORT.
- Published in:
- Arerugi: Japanese Journal of Allergology, 2024, v. 73, n. 2, p. 189
- By:
- Publication type:
- Article
Treatment patterns of systemic drug use in Japanese patients with plaque psoriasis: A retrospective chart review.
- Published in:
- Journal of Dermatology, 2024, v. 51, n. 2, p. 210, doi. 10.1111/1346-8138.17038
- By:
- Publication type:
- Article
Author Correction: Efficacy and Safety of Apremilast for the Treatment of Japanese Patients with Palmoplantar Pustulosis: Results from a Phase 2, Randomized, Placebo-Controlled Study.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
Paediatric pustulotic arthro‐osteitis patient with an IL36RN variant, heterozygous c.115+6T>C, who was successfully treated with tonsillectomy: A case report and literature review.
- Published in:
- Experimental Dermatology, 2024, v. 33, n. 1, p. 1, doi. 10.1111/exd.15016
- By:
- Publication type:
- Article
Real‐world retention rates and effectiveness of secukinumab in psoriasis: Results from a multicenter cohort study (RAILWAY).
- Published in:
- Journal of Dermatology, 2023, v. 50, n. 11, p. 1415, doi. 10.1111/1346-8138.16926
- By:
- Publication type:
- Article
Efficacy and Safety of Apremilast for the Treatment of Japanese Patients with Palmoplantar Pustulosis: Results from a Phase 2, Randomized, Placebo-Controlled Study.
- Published in:
- American Journal of Clinical Dermatology, 2023, v. 24, n. 5, p. 837, doi. 10.1007/s40257-023-00788-2
- By:
- Publication type:
- Article
Topical application of imatinib mesylate ameliorated psoriasis‐like skin lesions in imiquimod‐induced murine model via angiogenesis inhibition.
- Published in:
- Experimental Dermatology, 2023, v. 32, n. 6, p. 878, doi. 10.1111/exd.14790
- By:
- Publication type:
- Article
Assessment of flare frequency and severity of generalized pustular psoriasis in Japanese patients: A retrospective chart review study.
- Published in:
- JEADV Clinical Practice, 2023, v. 2, n. 2, p. 261, doi. 10.1002/jvc2.113
- By:
- Publication type:
- Article
English version of Japanese guidance for the use of oral Janus kinase inhibitors (JAK1 and TYK2 inhibitors) in the treatments of psoriasis.
- Published in:
- Journal of Dermatology, 2023, v. 50, n. 5, p. e138, doi. 10.1111/1346-8138.16797
- By:
- Publication type:
- Article
Topical application of imatinib mesylate suppresses vitamin D3 analog‐induced dermatitis in Balb/c mice.
- Published in:
- Experimental Dermatology, 2023, v. 32, n. 4, p. 413, doi. 10.1111/exd.14720
- By:
- Publication type:
- Article
Bimekizumab Efficacy and Safety in Japanese Patients with Plaque Psoriasis in BE VIVID: A Phase 3, Ustekinumab and Placebo-Controlled Study.
- Published in:
- Dermatology & Therapy, 2023, v. 13, n. 3, p. 751, doi. 10.1007/s13555-022-00883-y
- By:
- Publication type:
- Article
Efficacy and safety of spesolimab in Asian patients with a generalized pustular psoriasis flare: Results from the randomized, double‐blind, placebo‐controlled Effisayil™ 1 study.
- Published in:
- Journal of Dermatology, 2023, v. 50, n. 2, p. 183, doi. 10.1111/1346-8138.16609
- By:
- Publication type:
- Article
Efficacy and safety of risankizumab in Japanese patients with generalized pustular psoriasis or erythrodermic psoriasis: Primary analysis and 180‐week follow‐up results from the phase 3, multicenter IMMspire study.
- Published in:
- Journal of Dermatology, 2023, v. 50, n. 2, p. 195, doi. 10.1111/1346-8138.16667
- By:
- Publication type:
- Article
English version of Japanese guidance for use of biologics for psoriasis (the 2022 version).
- Published in:
- Journal of Dermatology, 2023, v. 50, n. 2, p. e41, doi. 10.1111/1346-8138.16691
- By:
- Publication type:
- Article
Efficacy and safety of mirikizumab in psoriasis: results from a 52‐week, double‐blind, placebo‐controlled, randomized withdrawal, phase III trial (OASIS‐1)*.
- Published in:
- British Journal of Dermatology, 2022, v. 187, n. 6, p. 866, doi. 10.1111/bjd.21743
- By:
- Publication type:
- Article
Bimekizumab Safety in Patients With Moderate to Severe Plaque Psoriasis: Pooled Results From Phase 2 and Phase 3 Randomized Clinical Trials.
- Published in:
- 2022
- By:
- Publication type:
- journal article
SAPHO syndrome and pustulotic arthro-osteitis.
- Published in:
- Modern Rheumatology, 2022, v. 32, n. 4, p. 665, doi. 10.1093/mr/roab103
- By:
- Publication type:
- Article
Efficacy and Safety of Certolizumab Pegol in Japanese Patients with Generalized Pustular Psoriasis and Erythrodermic Psoriasis: 52-Week Results.
- Published in:
- Dermatology & Therapy, 2022, v. 12, n. 6, p. 1397, doi. 10.1007/s13555-022-00741-x
- By:
- Publication type:
- Article
Efficacy and Safety of Apremilast in the Treatment of Patients with Mild-to-Moderate Psoriasis in Japan: Results from PROMINENT, A Phase 3b, Open-Label, Single-Arm Study.
- Published in:
- Dermatology & Therapy, 2022, v. 12, n. 6, p. 1469, doi. 10.1007/s13555-022-00747-5
- By:
- Publication type:
- Article
Unmet Educational Needs and Clinical Practice Gaps in the Management of Generalized Pustular Psoriasis: Global Perspectives from the Front Line.
- Published in:
- Dermatology & Therapy, 2022, v. 12, n. 2, p. 381, doi. 10.1007/s13555-021-00661-2
- By:
- Publication type:
- Article
Ixekizumab 80 mg Every 2 Weeks Treatment Beyond Week 12 for Japanese Patients with Generalized Pustular Psoriasis and Erythrodermic Psoriasis.
- Published in:
- Dermatology & Therapy, 2022, v. 12, n. 2, p. 481, doi. 10.1007/s13555-021-00666-x
- By:
- Publication type:
- Article
Comparison of Treatment Goals between Users of Biological and Non-Biological Therapies for Treatment of Psoriasis in Japan.
- Published in:
- Journal of Clinical Medicine, 2021, v. 10, n. 24, p. 5732, doi. 10.3390/jcm10245732
- By:
- Publication type:
- Article
Sustained efficacy and safety of guselkumab in patients with palmoplantar pustulosis through 1.5 years in a randomized phase 3 study.
- Published in:
- Journal of Dermatology, 2021, v. 48, n. 12, p. 1838, doi. 10.1111/1346-8138.16132
- By:
- Publication type:
- Article
Population pharmacokinetic and exposure–response analysis of apremilast in Japanese subjects with moderate to severe psoriasis.
- Published in:
- Journal of Dermatology, 2021, v. 48, n. 11, p. 1652, doi. 10.1111/1346-8138.16068
- By:
- Publication type:
- Article
Clinical characteristics and health‐care resource utilization in patients with generalized pustular psoriasis using real‐world evidence from the Japanese Medical Data Center database.
- Published in:
- Journal of Dermatology, 2021, v. 48, n. 11, p. 1675, doi. 10.1111/1346-8138.16084
- By:
- Publication type:
- Article
Clinical background of patients with psoriasiform skin lesions due to tumor necrosis factor antagonist administration at a single center.
- Published in:
- Journal of Dermatology, 2021, v. 48, n. 11, p. 1745, doi. 10.1111/1346-8138.16103
- By:
- Publication type:
- Article
Patient characteristics and burden of disease in Japanese patients with generalized pustular psoriasis: Results from the Medical Data Vision claims database.
- Published in:
- Journal of Dermatology, 2021, v. 48, n. 10, p. 1463, doi. 10.1111/1346-8138.16022
- By:
- Publication type:
- Article
Long‐term efficacy and safety of tildrakizumab in Japanese patients with moderate to severe plaque psoriasis: Results from a 5‐year extension of a phase 3 study (reSURFACE 1).
- Published in:
- Journal of Dermatology, 2021, v. 48, n. 6, p. 844, doi. 10.1111/1346-8138.15763
- By:
- Publication type:
- Article
Efficacy and safety of tildrakizumab in Japanese patients with moderate to severe plaque psoriasis: Results from a 64‐week phase 3 study (reSURFACE 1).
- Published in:
- Journal of Dermatology, 2021, v. 48, n. 6, p. 853, doi. 10.1111/1346-8138.15789
- By:
- Publication type:
- Article
Case of generalized pustular psoriasis preceded by acute generalized pustular bacterid‐like eruptions on the palms and soles.
- Published in:
- Journal of Dermatology, 2021, v. 48, n. 6, p. e250, doi. 10.1111/1346-8138.15845
- By:
- Publication type:
- Article
Effectiveness of omalizumab in two cases of normocomplementemic urticarial vasculitis due to perivascular mast cell infiltration.
- Published in:
- Arerugi: Japanese Journal of Allergology, 2021, v. 70, n. 2, p. 269, doi. 10.1016/j.alit.2020.09.012
- By:
- Publication type:
- Article
Dietary habits in Japanese patients with palmoplantar pustulosis.
- Published in:
- Journal of Dermatology, 2021, v. 48, n. 3, p. 366, doi. 10.1111/1346-8138.15719
- By:
- Publication type:
- Article
Long‐term analysis of adalimumab in Japanese patients with moderate to severe hidradenitis suppurativa: Open‐label phase 3 results.
- Published in:
- Journal of Dermatology, 2021, v. 48, n. 1, p. 3, doi. 10.1111/1346-8138.15605
- By:
- Publication type:
- Article
Pharmacodynamic analysis of apremilast in Japanese patients with moderate to severe psoriasis: Results from a phase 2b randomized trial.
- Published in:
- Journal of Dermatology, 2021, v. 48, n. 1, p. 80, doi. 10.1111/1346-8138.15596
- By:
- Publication type:
- Article
A case of Japanese pediatric cutaneous mastocytosis with disparate clinical classifications of maculopapular cutaneous mastocytosis and mastocytoma.
- Published in:
- 2020
- By:
- Publication type:
- Case Study
Correlation of the clinical severity of atopic dermatitis with ocular comorbidities.
- Published in:
- Journal of Cutaneous Immunology & Allergy, 2020, v. 3, n. 5, p. 109, doi. 10.1002/cia2.12127
- By:
- Publication type:
- Article
A case of microscopic polyangiitis initially presented with erythema multiforme‐like skin eruptions.
- Published in:
- 2020
- By:
- Publication type:
- Case Study
Characteristics of Japanese patients with pustulotic arthro‐osteitis associated with palmoplantar pustulosis: a multicenter study.
- Published in:
- International Journal of Dermatology, 2020, v. 59, n. 4, p. 441, doi. 10.1111/ijd.14788
- By:
- Publication type:
- Article
Efficacy and Safety of Guselkumab in Japanese Patients With Palmoplantar Pustulosis: A Phase 3 Randomized Clinical Trial.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Recent trends of ocular complications in patients with atopic dermatitis.
- Published in:
- Japanese Journal of Ophthalmology, 2019, v. 63, n. 5, p. 410, doi. 10.1007/s10384-019-00678-3
- By:
- Publication type:
- Article
Twenty‐four‐week interim analysis from a phase 3 open‐label trial of adalimumab in Japanese patients with moderate to severe hidradenitis suppurativa.
- Published in:
- Journal of Dermatology, 2019, v. 46, n. 9, p. 745, doi. 10.1111/1346-8138.14997
- By:
- Publication type:
- Article
Diagnostic histopathological features distinguishing palmoplantar pustulosis from pompholyx.
- Published in:
- Journal of Dermatology, 2019, v. 46, n. 5, p. 399, doi. 10.1111/1346-8138.14850
- By:
- Publication type:
- Article
Long‐term efficacy and safety of secukinumab in Japanese patients with moderate to severe plaque psoriasis: 3‐year results of a double‐blind extension study.
- Published in:
- Journal of Dermatology, 2019, v. 46, n. 3, p. 186, doi. 10.1111/1346-8138.14761
- By:
- Publication type:
- Article
Evaluation of the efficacy of granulocyte and monocyte adsorption apheresis on skin manifestation and joint symptoms of patients with pustulotic arthro‐osteitis.
- Published in:
- Journal of Dermatology, 2019, v. 46, n. 2, p. 144, doi. 10.1111/1346-8138.14717
- By:
- Publication type:
- Article
Allergic contact dermatitis caused by isopropyl lauroyl sarcosinate.
- Published in:
- 2019
- By:
- Publication type:
- Case Study
Key component of inflammasome, NLRC4, was identified in the lesional epidermis of psoriatic patients.
- Published in:
- Journal of Dermatology, 2018, v. 45, n. 8, p. 971, doi. 10.1111/1346-8138.14478
- By:
- Publication type:
- Article